Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Applied DNA Sciences Inc APDN

Technology Scientific & Technical Instruments
Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic... see more

Recent & Breaking News (NDAQ:APDN)

Applied DNA Provides Business Update on COVID-19 Diagnostics and Testing

Business Wire January 15, 2021

Applied DNA Announces Closing of $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Business Wire January 13, 2021

Applied DNA Announces Pricing of $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Business Wire January 11, 2021

U.S. FDA Lists Applied DNA's Linea(TM) COVID-19 Assay Kit as 1 of Only 2 EUA-Authorized Tests Able to Detect S-Gene Mutation Found in SARS-CoV-2 U.K. Variant (B.1.1.7)

Business Wire January 8, 2021

Applied DNA to Participate in the H.C. Wainwright BIOCONNECT 2021 Conference

Business Wire January 5, 2021

Applied DNA Announces Preliminary Estimated First Fiscal Quarter 2021 Revenues in the Range of $1.3 Million to $1.6 Million

Business Wire January 4, 2021

Applied DNA Partners with CLEARED4 on Pooled COVID-19 Surveillance Testing Program

Business Wire December 29, 2020

Applied DNA Reports 2020 Year End and Fiscal Fourth Quarter Financial Results

Business Wire December 17, 2020

Applied DNA Awarded Pooled Surveillance Testing Contract Valued at Up to $2.0 Million from Suffolk County (N.Y.) Government

Business Wire December 17, 2020

Compliance with New York State Winter COVID-19 Plan Drives Demand for Applied DNA's Pooled Surveillance Testing Program

Business Wire December 11, 2020

Applied DNA Schedules Fiscal 2020 Fourth Quarter Financial Results Conference Call for Thursday, December 17, 2020 at 4:30 PM EST

Business Wire December 8, 2020

Nutrition21 Transitions to Applied DNA's CertainT® Platform to Secure IP-protected Portfolio of Dietary Supplement Ingredients

Business Wire December 7, 2020

Applied DNA to Provide COVID-19 Surveillance Testing to Stony Brook Basketball

Business Wire December 1, 2020

Applied DNA, EvviVax, and GVS Receive Regulatory Approval to Conduct Veterinary Clinical Trial for Linear COVID-19 Vaccine Candidate

Business Wire November 30, 2020

Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3

Business Wire November 27, 2020

Applied DNA Significantly Expands Addressable Market for Linea(TM) COVID-19 Assay Kit via Successful Amendment to FDA EUA

Business Wire November 25, 2020

Applied DNA Secures Blanket Purchase Order for 10,000 Linea(TM) COVID-19 Tests

Business Wire November 12, 2020

Stony Brook University Hospital Launches COVID-19 Surveillance Testing Program Powered by Applied DNA's Assay Kit and Services

Business Wire November 10, 2020

Applied DNA Announces Linear DNA Orders from New Contract Research Customers for Use in RNA Vaccine and Adeno-Associated Virus Applications

Business Wire November 2, 2020

Applied DNA to Increase COVID-19 Surveillance Testing Utility for its Linea(TM) COVID-19 Assay Kits Through Expanded Use of Robotic Automation

Business Wire October 30, 2020